BTC 
ETH 
BNB 
XRP 
SOL 
TRX Uniqure stock falls as FDA sets May 1 decision date for Huntington's gene therapy
Investor's Business Daily reported that the FDA said Monday it will make an approval decision on Uniqure's Huntington's gene therapy by May 1. The same post states that Uniqure stock fell after the therapy landed at the FDA.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
The FDA said it will decide on Uniqure's Huntington's gene therapy by May 1.
“the FDA said Monday it will make an approval decision on Uniqure's Huntington's gene therapy by May 1”
Investor's Business Daily -
Uniqure stock fell after its Huntington's gene therapy landed at the FDA.
“Uniqure Stock Falls After Its Huntington's Gene Therapy Lands At The FDA”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-02 15:30 UTC. Labels are computed from the sources, not by the model.